Generic Lipitor Supply Adequate as Ranbaxy Recalls Pills

Ranbaxy Laboratories Ltd.’s recall and production halt of its version of the cholesterol pill Lipitor won’t create a supply shortage, U.S. regulators said.

Ranbaxy has stopped making the generic pills while it investigates how glass particles got into the product, the Food and Drug Administration said today in a statement. The company, based near New Delhi, announced Nov. 23 it had recalled the medicine. The FDA said it hasn’t received any reports of patients being harmed.